Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 42

Trial Status

Completed4

Role Distribution

Principal Investigator2
Other Roles2
PI Rate50%

Activity Timeline

Clinical Trials (4)

NCT05924685Phase 4Completed
PREPARE-iVAC Trial
COVID-19 VaccinesImmunosuppressionVaccine Response+1 more
PrincipalinvestigatorStart date: 2023-08-22
NCT05030974Phase 4Completed
RECOVAC Repeated Vaccination Study
Covid19Kidney DiseasesSARS-CoV2 Infection+1 more
PrincipalinvestigatorStart date: 2021-10-21
NCT04841785Completed
RECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients
Chronic Kidney DiseasesCovid19SARS-CoV Infection
StudydirectorStart date: 2021-04-22
NCT04741386Completed
The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study
Chronic Kidney DiseasesCovid19
StudydirectorStart date: 2021-02-17

Research Network

Collaboration Network

6 collaborators·11 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Marc H Hemmelder, MD PhD

Maastricht University Medical Center

Moderately Similar
1 trials

Shared therapeutic areas:

Chronic Kidney DiseasesCOVID-19SARS-CoV Infection

Worked with same sponsors:

University Medical Center Groningen
Collaborated on 1 trial
Similarity Score34%

Marlies EJ Reinders, MD PhD

Erasmus Medical Center

Related
1 trials

Shared therapeutic areas:

Chronic Kidney DiseasesCOVID-19

Worked with same sponsors:

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Erasmus Medical Center+2 more
Collaborated on 1 trial
Similarity Score24%

Luuk B Hilbrands, MD PhD

Radboud University Medical Center

Related
1 trials

Shared therapeutic areas:

Chronic Kidney DiseasesCOVID-19

Worked with same sponsors:

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Erasmus Medical Center+2 more
Collaborated on 1 trial
Similarity Score24%

Ron T Gansevoort, MD PhD

University Medical Center Groningen

Related
1 trials

Shared therapeutic areas:

Chronic Kidney DiseasesCOVID-19

Worked with same sponsors:

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Erasmus Medical Center+2 more
Collaborated on 1 trial
Similarity Score24%

Frederike J Bemelman, MD PhD

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Related
1 trials

Shared therapeutic areas:

Chronic Kidney DiseasesCOVID-19

Worked with same sponsors:

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Erasmus Medical Center+2 more
Collaborated on 1 trial
Similarity Score24%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVID-19SARS-CoV Infection
Similarity Score5%

Mohamed mamdouh Elsayed, MD

Lecturer

Related
11 trials

Shared therapeutic areas:

Chronic Kidney DiseasesCOVID-19
Similarity Score5%

Melda Saglam, PhD

Hacettepe University

Related
14 trials

Shared therapeutic areas:

Chronic Kidney DiseasesCOVID-19
Similarity Score5%

Naciye Vardar-Yagli, PhD

Hacettepe University

Related
14 trials

Shared therapeutic areas:

COVID-19Chronic Kidney Diseases
Similarity Score5%

Nadine Rouphael, MD

Emory University

Related
18 trials

Shared therapeutic areas:

Herpes ZosterVaccine Response
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT05924685Phase 4PrincipalInvestigator

PREPARE-iVAC Trial

COVID-19 VaccinesImmunosuppressionVaccine Response+1 more
Completed
NCT05030974Phase 4PrincipalInvestigator

RECOVAC Repeated Vaccination Study

Covid19Kidney DiseasesSARS-CoV2 Infection+1 more
Completed
NCT04841785StudyDirector

RECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients

Chronic Kidney DiseasesCovid19SARS-CoV Infection
Completed
NCT04741386StudyDirector

The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study

Chronic Kidney DiseasesCovid19
Completed

All 4 trials loaded